In Reply
- PMID: 27776055
- DOI: 10.1097/AOG.0000000000001724
In Reply
Comment on
-
Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.Obstet Gynecol. 2016 Jul;128(1):4-10. doi: 10.1097/AOG.0000000000001446. Obstet Gynecol. 2016. PMID: 27275812 Free PMC article. Review.
-
Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.Obstet Gynecol. 2016 Nov;128(5):1179. doi: 10.1097/AOG.0000000000001723. Obstet Gynecol. 2016. PMID: 27776054 No abstract available.
References
-
- Stanton A, McLeod C, Kissin W, Sonnenfeld J, Luckey JW. Evaluation of the buprenorphine Waiver Program: results from the SAMHSA/CSAT's evaluation of the buprenorphine Waiver Program. Available at: http://naabt.org/documents/StantonCPDDhandout2.pdf. Retrieved August 3, 2016.
-
- Hansen H, Siegel C, Case B, Bertollo D, DiRocco D, Galanter M. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res 2013;40:367–77.
-
- Krans EE, Bogan D, Richardson G, Park SY, Dunn SL, Day N. Factors associated with buprenorphine versus methadone use in pregnancy. Substance Abuse 2016 February 25 [Epub ahead of print].
-
- Opioid abuse, dependence, and addiction in pregnancy. Committee Opinion No. 524. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;119:1070–6.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources